ACP Support Letter to Congressional Leadership for the FY2023 Continuing Resolution (CR) But Expressing Disappointment that COVID-19 and Monkeypox Funding Was Not Included

ACP support letter to Congressional Leadership for the FY2023 Continuing Resolution (CR) but expressing disappointment that COVID-19 and monkeypox funding was not included.

Jonni M.

Schumer, McConnell, Pelosi, McCarthy, congressional leadership, public health emergency, PHE, Coronavirus, COVID-19, COVID: physicians, vaccines, anti viral, testing, pandemic, global, public health, supplemental, appropriations, funding, FY2022, FY2023, fiscal year 2022, fiscal year 2023, FY 2022, FY 2023, supplemental, Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023, H.R. 6833, continuing resolution, CR, stop gap, spending, variants, U.S. Department of Health and Human Services, HHS, public health emergency, PHE, monkeypox, diagnostic, booster, supply, variant, resources, claims, uninsured, treatment, monoclonal antibody treatments, testing capacity, patients, vulnerable, safety net, clinicians, global, global health, supplies, therapeutics, Strategic National Stockpile, SNS, Medicare, physician payment, cuts, Medicare physician fee schedule, National Suicide Prevention Lifeline, 988, Food and Drug Administration, FDA, prescription drugs, generic drugs, biosimilars, biosimilar, use fee agreements, UFA, $22.4 billon, $4.5 billion, personal protective equipment, PPE, Ryan White, community health clinics, CHC,

Tue, 09/27/2022 - 3:36 PM EDT

Tue, 09/27/2022 - 4:30 PM EDT

3

acp_support_letter_to_congressional_leadership_for_the_fy2023_continuing_resolution_2022.pdf

{"Author":"Jonni M.","CreationDate":"2022-09-27T15:36:05-04:00","Creator":"Microsoft\u00ae Word for Microsoft 365","Keywords":"Schumer, McConnell, Pelosi, McCarthy, congressional leadership, public health emergency, PHE, Coronavirus, COVID-19, COVID: physicians, vaccines, anti viral, testing, pandemic, global, public health, supplemental, appropriations, funding, FY2022, FY2023, fiscal year 2022, fiscal year 2023, FY 2022, FY 2023, supplemental, Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023, H.R. 6833, continuing resolution, CR, stop gap, spending, variants, U.S. Department of Health and Human Services, HHS, public health emergency, PHE, monkeypox, diagnostic, booster, supply, variant, resources, claims, uninsured, treatment, monoclonal antibody treatments, testing capacity, patients, vulnerable, safety net, clinicians, global, global health, supplies, therapeutics, Strategic National Stockpile, SNS, Medicare, physician payment, cuts, Medicare physician fee schedule, National Suicide Prevention Lifeline, 988, Food and Drug Administration, FDA, prescription drugs, generic drugs, biosimilars, biosimilar, use fee agreements, UFA, $22.4 billon, $4.5 billion, personal protective equipment, PPE, Ryan White, community health clinics, CHC,","ModDate":"2022-09-27T16:30:30-04:00","Producer":"Microsoft\u00ae Word for Microsoft 365","Title":"ACP Support Letter to Congressional Leadership for the FY2023 Continuing Resolution (CR) But Expressing Disappointment that COVID-19 and Monkeypox Funding Was Not Included","Pages":3}

2022